Welcome : Guest

GTX, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about GTX, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 26 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-09065
Price: $1300
Company Type: Public
Pages: 30
Date: November 2016
Market Data Tables: 26

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Cancer Market......5
Table 1: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......5
Table 2: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......6
Table 3: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......7
Table 4: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......8
Cancer Patients......9
Table 5: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......9
Table 6: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......10
Table 7: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......11
Table 8: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......12
Table 9: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......13
Table 10: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......14
Cancer-Associated Mucositis......15
Table 11: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......15
Breast Cancer......16
Table 12: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......16
Invasive Breast Cancer......17
Table 13: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......17
Table 14: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......18
Women's Health Drugs......19
Table 15: Women's Health Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......19
Urinary Incontinence Drugs......20
Table 16: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......20
Table 17: Urology Market by Category in North America and Europe (2015) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis / Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......21
Table 18: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......22
Table 19: Prevalence of Urinary Incontinence by Gender in the US (2015) - Percentage Share Breakdown for Men and Women......23
Table 20: Prevalence of Urinary Incontinence in Women (Age Group (18-44)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......24
Table 21: Prevalence of Urinary Incontinence in Women (Age Group (>60)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......25
Duchenne Muscular Dystrophy (DMD) Disease......26
Table 22: Duchenne Muscular Dystrophy (DMD) Disease Market by Therapy in the U.S (2015) - Percentage Breakdown by No. of Patients for Exon 44, Exon 45, Exon 46, Exon 51, Exon 53, and Others......26
Table 23: Duchenne Muscular Dystrophy (DMD) Disease Market by Therapy in European Union (2015) - Percentage Breakdown by No.of Patients for Exon 44, Exon 45, Exon 46, Exon 51, Exon 53, and Others......27
Breast Cancer Drugs......28
Table 24: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......28
Women's Health Therapeutics......29
Table 25: Market Shares of Leading Women's Health Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Merck Ltd., Novo Nordisk A/S, Pfizer, Inc., and Others......29
Urinary Incontinence Therapeutic......30
Table 26: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......30